• Principal Investigator
  • Board-Certified in Adult Psychiatry
  • Board- Eligible in Adolescent and Child Psychiatry
  • Conducted 111 Phase II-IV clinical trials in outpatient and inpatient facilities

Dr. Lopez completed undergraduate studies at Auburn University in Auburn, Alabama and graduate studies at East Tennessee State University in Johnson City, Tennessee, receiving a Bachelor of Science in Zoology and Medical Doctorate. He went on to complete an internship and residency program in adult psychiatry at the Medical University of South Carolina in Charleston, South Carolina and was later awarded a 2-year fellowship in child and adolescent psychiatry, also at the Medical University of South Carolina. He currently serves on the board of directors for Walk for Autism Charleston, a non-profit organization that helps fund scholarships for children with autism.

Dr. Lopez has extensive training in adult, adolescent and child psychiatry, specializing in psychotic and mood disorders and serving as a local authority on the treatment of autism spectrum disorders in children and adolescents. He has worked in numerous public and private mental health organizations and has served as medical director for several facilities.
Dr. Lopez currently serves as Chief Medical Officer for Palmetto Lowcountry Behavioral Health, an 80 bed, acute psychiatric hospital located in Charleston, South Carolina. Palmetto Lowcountry Behavioral Health specializes in the treatment of acute psychiatric and substance abuse issues. In addition, Dr. Lopez serves as a staff psychiatrist for Compass Carolina Health Systems where he maintains an extensive outpatient practice. He treats a variety of psychiatric disorders including mood disorders, psychotic disorders, neurological disorders, learning disabilities and addiction.

Dr. Lopez has conducted clinical research trials since 2000 serving as the principal and subinvestigator on numerous II-IV trials. He has served as principal investigator on clinical trials for a range of adolescent and pediatric populations including ADHD, autism spectrum disorders, bipolar disorder, depression and schizophrenia. He has also served as subinvestigator on a number of trials for adults, children and adolescents including trials for mood disorders, psychotic disorders, ADHD, PTSD, and substance abuse.